DHTKD1 and cancer: Malignant tumours, when expressing adenovirus E1A, are very sensitive to in vivo treatment with DNA-damaging agents, including irradiation (Sanchez-Prieto et al, 1995, 1996; 1998; Martin-Duque et al, 1999).